From: Survivin expression and its clinical significance in pancreatic cancer
 |  | No. of case |
---|---|---|
Age* |  | 59 (33–76) |
M:F | Â | 36:13 |
Chief Complaint | Pain | 20(40.8%) |
 | Jaundice | 18(36.7%) |
 | Indigestion | 6(12.2%) |
 | Others | 5(10.1%) |
Location | Head | 35(71.4%) |
 | Body | 1(2.0%) |
 | Tail | 7(14.3%) |
 | Body & Tail | 6(12.3%) |
Stage | I | 8(16.3%) |
 | II | 26(53.1%) |
 | III | 10(20.4%) |
 | IV | 5(10.2%) |
Adjuvant treatment | Yes | 20(40.8%) |
 | No | 14(28.6%) |
Recurrence after curative surgery | 18/35+ |